SEOM clinical guidelines in advanced and recurrent breast cancer (2018)
Clin. transl. oncol. (Print)
; 21(1): 31-45, ene. 2019. tab
Article
em En
| IBECS
| ID: ibc-183342
Biblioteca responsável:
ES1.1
Localização: BNCS
ABSTRACT
Although the metastasic breast cancer is still an incurable disease, recent advances have increased significantly the time to progression and the overall survival. However, too much information has been produced in the last 2 years, so a well-based guideline is a valuable document in treatment decision making. The SEOM guidelines are intended to make evidence-based recommendations on how to manage patients with advanced and recurrent breast cancer to achieve the best patient outcomes based on a rational use of the currently available therapies. To assign a level of certainty and a grade of recommendation the United States Preventive Services Task Force guidelines methodology was selected as reference
RESUMEN
No disponible
Texto completo:
1
Coleções:
06-national
/
ES
Base de dados:
IBECS
Assunto principal:
Neoplasias da Mama
/
Metástase Neoplásica
/
Recidiva Local de Neoplasia
Limite:
Female
/
Humans
Idioma:
En
Revista:
Clin. transl. oncol. (Print)
Ano de publicação:
2019
Tipo de documento:
Article